The GO and KEGG pathway of targets of XYS in the treatment of OC were involved in 338 signaling pathways, including the PI3K-Akt signaling pathway, bladder cancer, pancreatic cancer, hepatitis B, microRNAs in cancer, and HIF-1 signaling pathway. This evidence concerns the gene PIK3CA and urinary bladder carcinoma.